Owlet, Inc. (OWLT) AI Stock Analysis
OWLT AI stock analysis summary
AI ResearchOwlet, Inc. (OWLT) is a digital parenting platform known for infant health monitors like the Smart Sock and Dream Duo. In FY2025, revenue increased 35.4% to $105.7M, and quarterly revenue rose 29.9% year-over-year in the period ended June 30, 2026. The company maintains a net cash balance of $27.3M with total debt of $3.6M.
- Market cap
- $120.1M
- Revenue (TTM)
- $114.4M
- P/E
- —
- 1Y return
- -52.2% S&P 500 16.8%
- Avg. target
- $13.00 216.3% vs last close
Bull case
- Owlet achieved 35.4% revenue growth in FY2025 to reach $105.7M, followed by 29.9% year-over-year revenue expansion in the quarter ended June 30, 2026.
- The balance sheet carries $27.3M in net cash with total debt of only $3.6M as of June 30, 2026.
- Covering Wall Street analysts unanimously rate the stock a Strong Buy across 5 ratings, with a mean price target of $13.00.
Bear case
- Owlet reported a net loss of -$39.7M and free cash flow of -$11.1M in FY2025.
- Shareholder equity has faced substantial dilution, with the share count increasing 262.6% over a 5-year span.
- The stock fell 52.2% over the trailing twelve months and touched its 52-week low of $4.11.
What Owlet does
Owlet, Inc. is a Lehi, Utah-based digital parenting platform founded in 2012 that provides real-time data and insights to parents. The company's core product is the Smart Sock, an infant monitor tracking oxygen levels, heart rates, and sleep patterns. Its broader product portfolio includes the Dream Sock app for personalized sleep recommendations, the Cam app for remote video streaming, and Dream Lab, an interactive online platform for infant sleep routines. Owlet also offers the Dream Duo, which integrates a wearable sock monitor with HD video streaming and a digital sleep coaching system.
Growth and profitability
Revenue contracted from $75.8M in FY2021 to $54.0M in FY2023 before rebounding 44.5% in FY2024 to $78.1M and 35.4% in FY2025 to $105.7M, representing a 5-year compound annual growth rate of 7.0%. Gross margin expanded from 33.7% in FY2022 to 50.6% in FY2025. Operating margin improved from -122.3% in FY2022 to -7.8% in FY2025, while trailing twelve months operating margin reached 5.1%. Net income was -$39.7M in FY2025 with EPS of -$0.22, up from -$6.36 in FY2021. For the quarter ended June 30, 2026, quarterly revenue grew 29.9% year-over-year, bringing trailing twelve months revenue to $114.4M.
Balance sheet and cash flow
As of June 30, 2026, Owlet held $30.9M in cash and short-term investments and $3.6M in total debt, yielding a net cash position of $27.3M. The company reported a current ratio of 1.64 and a debt-to-equity ratio of 0.09 on shareholders' equity of $38.9M. In FY2025, operating cash flow was -$10.8M, free cash flow was -$11.1M, and capital expenditures were $273,000. Over a 5-year period, the company's share count increased 262.6%.
Valuation and performance
Owlet trades at a price-to-sales multiple of 1.0x and an enterprise value to revenue multiple of 1.3x, both below the median of its US-listed Healthcare peers of 4.1x sales. The company has a market capitalization of $120.1M and a price-to-book ratio of 6.1x. At the last close of $4.11, the stock traded 40.8% below its 200-day average. Over the past year, Owlet shares fell 52.2% while the S&P 500 returned 16.8%, and over five years the stock fell 92.4% against an 83.0% gain for the benchmark.
What analysts expect
Wall Street coverage consists of 5 Strong Buy ratings, with zero Buy, Hold, or Sell ratings. The mean price target is $13.00, representing a 216.3% premium over the last close of $4.11. For the fiscal year ending December 31, 2026, analysts estimate revenue of $119.8M and EPS of $0.25, representing 327.3% EPS growth. Owlet has beaten EPS estimates in each of the last 4 quarters, and its next earnings report date is November 12, 2026.
Key risks and what to watch
- Owlet has generated negative free cash flow in each of the last five fiscal years, including -$11.1M in FY2025.
- The stock carries elevated market risk with a beta of 1.91 and a 74.6% decline year-to-date.
- Trailing twelve months return on equity is -526.2%, reflecting persistent balance sheet deficits.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this OWLT AI stock analysis
This page is an AI-written research summary of Owlet, Inc. (OWLT). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: OWLT income statement, OWLT balance sheet, OWLT key metrics, OWLT analyst forecast, OWLT chart. See the OWLT stock overview for the latest quote and news.
OWLT AI stock analysis FAQ
What products does Owlet sell?
Owlet develops digital parenting products including the Smart Sock infant monitor, the Dream Sock app, the Cam video streaming app, Dream Lab sleep routines, and the Dream Duo monitoring system.
What is Owlet's debt and cash position?
As of June 30, 2026, Owlet held $30.9M in cash and short-term investments against $3.6M in total debt, resulting in net cash of $27.3M.
Does Owlet pay a dividend?
Owlet does not pay a dividend on its common stock.
When is Owlet's next earnings report date?
Owlet is scheduled to report earnings on November 12, 2026.